Novogene Co., Ltd. (SHA:688315)
China · Delayed Price · Currency is CNY 12.87
+0.29 (2.31%)
Jun 23, 2026, 3:00 PM CST
Novogene Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Novogene stock has a consensus rating of "Strong Buy" and an average price target of ¥17.25. The average 1-year stock price forecast is 34.03% higher than the current stock price, while the lowest is ¥16.50 (+28.21%) and the highest is ¥18.00 (+39.86%).
Price Target: ¥17.25 (+34.03%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Novogene stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Feb '26 | Apr '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 2 | 3 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 4 | 3 | 4 | 3 |
Financial Forecast
Revenue This Year
2.46B
from 2.21B
Increased by 11.10%
Revenue Next Year
2.73B
from 2.46B
Increased by 11.18%
EPS This Year
0.52
from 0.32
Increased by 62.50%
EPS Next Year
0.60
from 0.52
Increased by 15.38%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.5B | ||
| Avg | 2.5B | ||
| Low | 2.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.6% | ||
| Avg | 11.1% | ||
| Low | 10.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.52 | ||
| Avg | 0.52 | ||
| Low | 0.52 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 62.5% | ||
| Avg | 62.5% | ||
| Low | 62.5% |